Toronto Dominion Bank
AMED

Toronto Dominion Bank’s Amedisys AMED Stock Holding History

Toronto Dominion Bank’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,000
Closed -$492K – 1925
2025
Q2 		$492K Sell
5,000
-5,000
-50% -$473K ﹤0.01% 1185
2025
Q1 		$926K Sell
10,000
-87,135
-90% -$8.03M ﹤0.01% 1084
2024
Q4 		$8.82M Buy
+97,135
New +$8.92M 0.01% 574
2023
Q4 		– Sell
-51,500
Closed -$4.81M – 1584
2023
Q3 		$4.81M Buy
+51,500
New +$4.76M 0.01% 698

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Toronto Dominion Bank's AMED Position: Q3 2025 in Review

Toronto Dominion Bank sold out of Amedisys (AMED) in Q3 2025, closing a stake of 5,000 shares — an estimated $492K sold.

Toronto Dominion Bank first reported a position in AMED in Q3 2023 and held it in 4 quarters. The position peaked at $8.82M in Q4 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Toronto Dominion Bank reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 5,000 Amedisys shares in Q3 2025, an estimated $492K.
  • Toronto Dominion Bank first reported a position in Amedisys in Q3 2023 and held it in 4 quarters.
  • Toronto Dominion Bank's Amedisys position peaked at $8.82M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Toronto Dominion Bank's 13F filing for Q3 2025, filed 14 Nov 2025.